Mesoblast LimitedASX: MSB

FDA clears phase 2 clinical trial for rheumatoid arthritis

Feb 10, 2016 at 8:19 PM EST · Issued by Mesoblast Limited

Filed with ASX · Feb 10, 2016 at 8:19 PM EST

6ix hasn’t read this filing yet.

Follow Mesoblast into a list and get an email when it puts out news.